Fusion to green fluorescent protein improves expression levels of Theileria parva sporozoite surface antigen p67 in insect cells by Kaba, S.A. et al.
Fusion to green ﬂuorescent protein improves expression
levels of Theileria parva sporozoite surface antigen
p67 in insect cells
S. A. KABA1,2, V. NENE2#, A. J. MUSOKE2, J. M. VLAK1 and M. M. VAN OERS1*
1Laboratory of Virology, Wageningen University, Binnenhaven 11, 6709 PD, Wageningen, The Netherlands
2 International Livestock Research Institute, P.O. Box 30709, Nairobi, Kenya
(Received 27 April 2002; revised 22 July 2002; accepted 23 July 2002)
SUMMARY
East Coast fever (ECF) is a fatal disease of cattle caused by the protozoan parasite Theileria parva. The development of a
subunit vaccine, based on the sporozoite-speciﬁc surface antigen p67, has been hampered by diﬃculties in achieving high-
level expression of recombinant p67 in a near-authentic form. Therefore two sets of recombinant baculovirus vectors were
constructed. The ﬁrst set, encoding various regions of p67, produced low levels of the corresponding p67 domains in High
FiveTM cells, despite the presence of large amounts of p67 RNA. The second, consisting of p67 domains fused to the
carboxy-terminus of GFP expressed signiﬁcantly higher levels of p67 protein. The GFP : p67 fusion proteins were
recognized by a sporozoite-neutralizing monoclonal antibody (TpM12) raised against native p67 whereas non-fused full
length p67 expressed in insect cells was not recognized. GFP-tagging therefore, appeared to enhance the stability of p67
and to conserve its folding. The high-level expression of p67 domains in a more authentic form is an important step
towards the development of an eﬀective subunit vaccine against ECF.
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INTRODUCTION
Theileria parva is a tick-transmitted protozoan para-
site of cattle, which causes East Coast fever (ECF).
This disease is of major economic importance
throughout east, central and southern Africa. The
brown ear tick, Rhipicephalus appendiculatus, trans-
mits the sporozoite stage of the parasite. The sporo-
zoites enter host lymphocytes where they develop
into intracellular multinucleate schizonts resulting
in a fatal lymphoproliferative and destructive dis-
ease (for reviews see Norval, Perry & Young, 1992;
Dobbelaere & Heussler, 1999).
The sporozoite surface protein p67 synthesized
during sporogony within the tick plays an essential
role in the invasion process (Dobbelaere & Spooner,
1985;Dobbelaere,Shapiro&Webster, 1985;Dobbe-
laere et al. 1985). Monoclonal antibodies directed
against p67 block (Dobbelaere et al. 1984), and
soluble p67 competitively inhibits (Shaw et al. 1995)
invasion of bovine lymphocytes by the sporozoites.
P67 contains 709 amino acid residues and has the
characteristics of a transmembrane protein. It has
a secretory signal sequence at the N-terminus, 7
potential N-linked glycosylation sites and a hydro-
phobic C-terminal tail (Nene et al. 1992). P67 is con-
served among sporozoites isolated from diﬀerent
cattle-derivedT. parva stocks (Nene et al. 1996), thus
making it a good candidate for a broad-spectrum
subunit vaccine against ECF.
To investigate its vaccine potential, p67 has been
cloned and expressed in Escherichia coli (Musoke
et al. 1992) as a fusion to the non-structural NS1
protein of inﬂuenza virus A. Cattle immunized with
NS1-p67 generated high titres of p67-speciﬁc anti-
bodies with a strong in vitro neutralizing activity
againstT. parva sporozoites. On challenge with LD70
of stabilated sporozoites, 70% of the immunized
cattle were protected against ECF. A relatively high
dose of NS1-p67 was required to achieve this level of
protection. In addition NS1-p67 was not recognized
by TpM12, a neutralizing monoclonal antibody
raised against native p67 (Musoke et al. 1984). These
observations indicate that the E. coli-expressed p67
was not in a native conformation or that it lacked
characteristic post-translational modiﬁcations, such
as glycosylation, which might be required for com-
plete protective immune responses.
The baculovirus–insect cell expression system has
been used in an attempt to express p67 in more
authentic forms with the proper folding and modi-
ﬁcations (Nene et al. 1995). Attempts to generate
a full-length p67 in insect cells were frustrated by
the fact that recombinant p67 was produced at a low
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level, the product was only partially processed and
not transported to the cell membrane. This insect
cell-derived p67 was essentially produced in a non-
native form. Cattle immunized with the baculovirus-
derived p67 showed a similar response to animals
immunized with the NS1-p67 product. The lack of
suﬃcient quantities of near-authentic recombinant
p67 hampers the evaluation of the full potential of
p67 as a vaccine (Nene et al. 1995). Waldo et al.
(1999) ﬁrst suggested that green ﬂuorescent protein
(GFP) might enhance stability of GFP fusion
proteins. Indeed, in prokaryotic expression systems,
GFP-tagging increased both stability and solubility
of recombinant proteins (Rucker et al. 2001). Since
the ﬁrst expression ofGFPwith recombinant baculo-
viruses (Reilander, Haase & Maul, 1996), GFP has
been widely used as a ﬂuorescence marker for gene
expression, protein localization and traﬃcking, and
protein–protein interactions by fusing its coding
sequence to that of the protein of interest (Wilson
et al. 1997).
In this study we sought to evaluate whether GFP
fusion could enhance the stability and hence the
expression levels of p67 in insect cells as well as
induce/preserve its native conformation, by express-
ing various p67 subdomains either as separate open
reading frames (ORFs) or as C-terminal fusions to
GFP. We report here the high-level expression of
p67 domains in a more authentic form in insect cells.
MATERIALS AND METHODS
Cells and viruses
Trichoplasia niHigh-FiveTM insect cells (Invitrogen)
were maintained in Grace’s supplemented insect
medium (Invitrogen) with 10% foetal bovine serum
(FBS) as monolayer cultures at 27 xC. For routine
cell maintenance, propagation and virus infection,
standard procedures were followed (Summers &
Smith,1987;King&Possee, 1992).Ascontrol viruses
the Autographa californica multicapsid nucleopoly-
hedrovirus (AcMNPV), strain E2 (Smith, Vlak &
Summers, 1983), and the recombinant baculovirus,
BEV-p67 (Nene et al. 1995) were used. BEV-p67
is a recombinant baculovirus carrying the complete
p67 protein including its native signal and trans-
membrane sequences.
Construction of recombinant baculoviruses
Theileria parva cDNA sequences (Fig. 1A) encoding
the N-terminus (p67N21–225), the central region
(p67M226–571), the C-terminus (p67C572–651) as well
as the full-length p67 protein (p67DSS21–651) were
PCR-ampliﬁed from a pMG1-p67 clone (Musoke
et al. 1992) using extended primers that introduced
BssHII/SalI/SstI or HindIII/ClaI restriction sites
(see Table 1). In contrast to the complete p67
protein expressed by recombinant BEV-p67 (Nene
et al. 1995), the p67DSS domain excluded the auth-
entic p67 signal and transmembrane anchor se-
quences. The PCR products were cloned into
pGEM-T (Promega) and sequences of the inserts
were veriﬁed by automated sequencing.
The DNA sequence encoding GFP was ampliﬁed
from a pBluescript-GFP clone (kindly provided by
Gerard van der Krogt; Laboratory of Molecular
Biology, Wageningen University) by using extended
primers to intoduce NcoI/NsiI or BamHI–ClaI/
HindIII–SstI sites (Table 1). The PCR products
were cloned into pGEM-T (Promega). GFP was
re-cloned into the plasmids pFastBacDual (pFBD)
and pFastBacHTb (pFBhis) (Invitrogen). GFP was
cloned as NcoI–NsiI fragment downstream of the
p10 promoter in pFastBacDual generating the par-
ental plasmid, pFBDp10GFP (Fig. 1B; 1), for non-
fused expression. In the pFastBacHT vector, GFP
was cloned as BamHI–SstI fragment generating the
parental plasmid for the GFP fusions, pFBhisGFP
(Fig. 1C; 1).
To generate non-fused constructs, p67C, p67N
and p67M were cloned as SstI–HindIII fragments
downstream of the polyhedrin promoter in the
pFBDp10GFP vector, generating the donor plas-
mids: pFBDp10GFP-php67C, pFBDp10GFP-
php67N and pFBDp10GFP-php67M (Fig. 1B; 2,
3, 4 respectively). Cloning of the p67 domains as
SstI–HindIII fragments into the pFBhisGFP vector
resulted in in-frame end-to-end gene fusion of the
p67 domains to the C-terminus of GFP, generating
theGFP :p67 fusion constructs: pFBhisGFP :p67C,
pFBhisGFP :p67N, pFBhisGFP :p67M and pFB-
hisGFP :p67DSS (Fig. 1C; 2, 3, 4, 5). Recombinant
baculoviruses encoding the non-fused p67 protein
domains were generated via the Bac-to-BacTM bac-
ulovirus expression system (Luckow et al. 1993;
Invitrogen), resulting in Ac-p67N, Ac-p67M, Ac-
p67C and the control virus Ac-GFP. The recombi-
nant baculoviruses Ac-hisGFP :p67N, Ac-hisGFP :
p67M, Ac-hisGFP :p67C, Ac-hisGFP :p67DSS en-
coding the fusion proteins and the control, Ac-
hisGFP were also generated.
Protein analysis
For the analysis of recombinant protein expression,
1r106 T. ni High FiveTM cells were seeded into
35 mm2 Petri dishes and infected with the various
recombinant viruses at a multiplicity of infection
(MOI) of 10 plaque-forming units (pfu) per cell.
At 72 h post-infection (p.i.) cells were harvested
and washed in 1 ml of phosphate-buﬀered saline
(PBS) at 4 xC. Finally the pellet was re-suspended
in 100 ml of ice-cold PBS. Protein concentrations
were determined using Bradford reagent (Bio-Rad).
Samples containing 2.5 mg total protein were analy-
sed in 15% (non-fused samples) or 10% (fusion
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proteins) SDS–PAGE gels, as described by Laemmli
(1970). Proteins were visualized by Coomassie Bril-
liant blue (CBB) staining or subjected to Western
analysis. Monoclonal antibodies, ARIII 22.7 and
ARIII 21.4 (Nene et al. 1999) speciﬁc for p67N and
C respectively, were used. The polyclonal anti-
bodies, rabbit Rat 44 and bovine BJ 36 (Nene et al.
1999) raised against the complete p67 protein were
used for p67M and p67DSS respectively. All anti-
bodies were used at a dilution of 1 : 200. For the
GFP :p67 fusion proteins, monoclonal antibodies
against the polyhistidine tag (Sigma) or a polyclonal
antibody against GFP (both at a dilution of 1 : 5000)
were used. As the second antibody, rabbit anti-
mouse immunoglobulins (for themonoclonals), anti-
bovine immunoglobulins (for BJ 36), or swine anti-
rabbit immunoglobulins (for the aGFP) conjugated
to horseradish peroxidase (HRP) (DAKO, A/S,
Denmark) were used at a dilution of 1 : 5000. The
HRP substrate, 4-chloro-1-naphthol (Bio-Rad) was
used to detect the p67 recombinant proteins.
Puriﬁcation and dot blot analysis
The polyhistidine tag was exploited to purify the
fusion proteins using TALONspin IMAC columns
(CLONTECH Laboratories). High FiveTM insect
cells were infected with the recombinant viruses at
Fig. 1. Schematic representation of non-fused p67 (B) and GFP : p67 (C) fusion constructs. (A) The Theileria parva
p67 open reading frame: SP (amino acid 1–20) is the p67 signal peptide; p67N (amino acid 21–225) the amino terminus;
p67M (amino acid 226–571) the middle region; p67C (amino acid 572–651) is the carboxy terminus and TMR
represents the transmembrane region. (B) The various pFastBacDual constructs: GFP was inserted as a NcoI–NsiI
fragment downstream of the p10 promoter while the various p67 domains were inserted asHindIII–SstI fragments under
the transcriptional control of the polyhedrin (ph) promoter. (C) The various GFP : p67 fusion constructs. GFP was ﬁrst
cloned into the pFastBacHTb vector as BamHI–SstI fragment to generate the vector pFBhisGFP. The various p67
domains were then inserted into the pFBhisGFP vector as SstI–HindIII fragments resulting in an end-to-end gene
fusion of the p67 domains to the C-terminus of GFP. The pFastBacHTb vector encodes a hexa-polyhistidine sequence
allowing N-terminal His-tagging of the foreign protein to facilitate puriﬁcation. S=SstI, H=HindIII, Ns=NsiI,
N=NcoI, B=BamHI.
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a MOI of 10 pfu per cell and collected at 72 h p.i.
Cells were concentrated and clariﬁed cytoplasmic
extracts were applied to the columns. After washing
withbuﬀer (50 mMsodiumphosphate, 300 mMNaCl,
pH 7.0) containing 25 mM imidazole to remove un-
bound and weakly bound proteins, the polyhisti-
dine-tagged GFP :p67 fusion proteins were eluted
from the column by increasing the imidazole con-
centration to 200 mM.
To examine the antigenic authenticity of the insect
cell-derivedGFP :p67fusionproteins,dotblotanaly-
sis was performed. Five mg of the puriﬁed GFP :p67
fusion proteins and 10 mg of total cell lysate of in-
fected T. ni High FiveTM insect cells were spotted
on a nitrocellulose membrane and allowed to dry.
Proteins were denatured by adding 1/20 volume of
b-mercaptoethanol and 1/4 volume of 4-fold sample
buﬀer (40 mM Tris–HCl, pH 8.0, 4 mM EDTA, 8%
SDS) and incubation at 95 xC for 10 min. Dupli-
cate blots were incubated with TpM12 (1 : 50) or
ARIII 22.7 (1 : 200) for 1 h at room temperature,
washed and further incubated with goat anti-mouse
immunoglobulins conjugated with horseradish per-
oxidase (Amersham) at a dilution of 1 : 5000. En-
hanced chemiluminescence (ECL) (Amersham) was
used for detection. The insect cell-derived p67 ex-
pressed by Nene et al. (1995), indicated as BEV-
p67, was compared with these GFP :p67 fusionT
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Fig. 2. SDS–PAGE and Western blot analysis of
non-fused p67 proteins. Trichoplusia niHigh FiveTM insect
cells were mock-infected (lane 1) or infected with Ac-wt
virus (lane 2) or recombinant viruses BEV-p67 (lane 3),
Ac-GFP (lane 4), Ac-p67N (lane 5), Ac-p67M (lane 6),
Ac-p67C (lane 7) and harvested at 72 h p.i. Total protein
(2.5 mg) was resolved in 15% SDS–PAGE and stained with
Coomassie Brilliant blue (A) or subjected to immunoblot
analysis using the p67N-speciﬁc monoclonal antibody
ARIII 22.7, the p67M-speciﬁc polyclonal antibody Rat 44
or the p67C-speciﬁc monoclonal antibody ARIII 21.4 (B).
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proteins. The same amount (5 mg) of puriﬁed E.
coli-expressed p67N, and hisGFP proteins as well
as mock and Ac-wt infected cell lysates containing
10 mg total protein were used as controls.
Transcript analysis
T. ni High FiveTM insect cells (1.0r106) were in-
fected with the recombinant viruses Ac-p67N, Ac-
p67M, Ac-p67C, and Ac-GFP at a MOI of 10 pfu/
cell and harvested at 24, 48 and 72 h p.i. Total RNA
was isolated using the single-step acid guanidin-
ium thiocyanate–phenol–chloroform RNA extrac-
tion method described by Chomczynski & Sacchi
(1987). Five ng RNA were resolved in 1.4% agarose
gel and Northern blot analysis was carried out as
described in Pelle´ & Murphy (1993). The RNA was
ﬁxed to the ﬁlter by UV light cross-linking. The
ﬁlter was hybridized to a PCR-ampliﬁed p67 (full
length) probe, labelled with a32P-dCTP by random
primed labelling with Klenow (Promega).
RESULTS
Expression of p67 subdomains in insect cells
To enhance the expression levels of p67 in insect
cells, subregions of p67 rather than the complete
p67 protein (Nene et al. 1995) were expressed. The
domains of p67 expressed in this study were an
N-terminal domain (p67N21–225), the central region
(p67M226–571) and a C-terminal domain (p67C572–651)
as well as the full-length protein without its
native signal sequence and transmembrane region
(p67DSS21–651) (Fig. 1A). The p67N, p67M and
p67C domains were cloned and expressed as separate
open reading frames (non-fusedconstructs) (Fig. 1B).
In a second experiment, each p67 domain was fused
to the C-terminus of GFP and expressed as a fusion
protein (Fig. 1C).
T. niHigh FiveTM cells infected with recombinant
viruses encoding these diﬀerent p67 subdomains
(non-fused and fused) were analysed in SDS–PAGE
and stained with Coomassie Brilliant blue (CBB) or
Fig. 3. Northern blot analysis of non-fused p67 transcripts. Total RNA (5 mg) was extracted from mock-infected
Trichoplusia ni High FiveTM insect cells (lanes 1), or cells infected with Ac-wt virus (lanes 2) or the recombinant viruses
Ac-p67N (lanes 3), Ac-p67M (lanes 4), Ac-p67C (lanes 5) at 24, 48 or 72 h p.i. Total RNA was resolved in a 1.4% agarose
gel and transferred to a Nylon ﬁlter. The ﬁlter was hybridized to a radioactively labelled p67 DNA probe. The ﬁlm was
exposed overnight. The sizes of an RNA marker are indicated in kilobases.
Fig. 4. SDS–PAGE and Western blot analysis of
GFP : p67 fusion proteins. Trichoplasia ni High
FiveTM insect cells (lane 1) were infected with the
Ac-wt virus (lane 2), or recombinant viruses BEV-p67
(lane 3), Ac-hisGFP (lane 4), Ac-hisGFP : p67N (lane 5),
Ac-hisGFP : p67M (lane 6), Ac-hisGFP : p67C (lane 7),
Ac-hisGFP : p67DSS (lane 8) and harvested at 72 h p.i.
Proteins (2.5 mg) were resolved in 10% SDS–PAGE and
stained with Coomassie Brilliant blue (A) or subjected to
immunoblot analysis using a monoclonal antibody against
the hexa-Histidine tag (B). The dots (in A) indicate the
various GFP fusion proteins.
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subjected to immunoblot analysis. In the Coomassie-
stained gel of the non-fused p67 recombinants, the
p67 subdomains p67N, p67M and p67C could not
be detected (Fig. 2A, lanes 5–7). A protein with the
expected electrophoretic mobility for GFP was ob-
served for all recombinants (Fig. 2A, lanes 4–7). The
medium of cells infected with Ac-GFP, Ac-p67N,
Ac-p67M and Ac-p67C turned green as early as 24 h
p.i. GFP expression was conﬁrmed by the green
ﬂuorescence of the protein under UV-light and by
Western blot analysis using aGFP polyclonal anti-
body (DAKO) (results not shown), indicating that
the infection had been successful. These results indi-
cate that the expression levels for the subdomains
were not signiﬁcantly increased compared to the full-
length p67 (Nene et al. 1995) expressed in insect cells
(Fig. 2A, lane 3).
In immuno-blot analysis a reaction with p67 anti-
bodies was observed for BEV-p67 which was absent
in the mock, Ac-wt and Ac-GFP samples (Fig. 2B,
lanes 1–4). The monoclonal antibodies, ARIII 22.7,
RAT 44 and ARIII 21.4, directed against p67N,
p67M and p67C, respectively, showed that p67N,
p67M and p67C proteins were expressed, although
at low levels, since they could not be detected by
Coomassie staining (Fig. 2A). P67M and to a lesser
extent p67N showed degradation (Fig. 2B, lanes
5–7). The major product of p67N was detected as a
45 kDa protein instead of the expected 22 kDa (Fig.
2B, lane 5). In Ac-p67M infected cells a 38 kDa
protein was detected as expected for p67M protein
(Fig. 2B, lane 6). P67C was detected as 2 separate
major proteins of 8.6 kDa, the expected mobility for
p67C, and of 28.0 kDa, 3 times the predicted size of
p67C (Fig. 2B, lane 7).
To investigate whether the low level of expression
of p67 domains observed was due to low transcrip-
tion, we examined p67 transcripts at diﬀerent times
post-infection. Total RNA was puriﬁed from cells
mock-infected or infected with Ac-wt, Ac-p67N,
Ac-p67M and Ac-p67C viruses and subjected to
Northern blot analysis using a p67-speciﬁc probe.
The p67 probe did not hybridize to mRNA puriﬁed
from mock and Ac-wt infected cells (Fig. 3, lanes 1
and 2). In the recombinant virus-infected cells, p67
transcripts were easily detected at 24 h p.i. and the
amount increased at 48 h p.i. Transcripts were still
observed at 72 h p.i. (Fig. 3, lanes 3–5). The amount
of transcript was, however, not reﬂected in the level
of p67 proteins observed (see Fig. 2A), suggesting
that the low level of expression of p67 subdomains
might be due to instability of the end-products.
To overcome this problem, p67 subdomains were
expressed as carboxy-terminal fusion proteins to
GFP (Fig. 1C). T. niHigh FiveTM cells were infected
with the recombinant baculoviruses Ac-hisGFP, Ac-
hisGFP :p67N, Ac-hisGFP :p67M, Ac-hisGFP :
p67C, Ac-hisGFP :p67DSS and total proteins from
infected cell lysates were resolved in SDS–PAGE
and stained with CBB or subjected to immunoblot
analysis. In the control lanes no p67-speciﬁc proteins
were observed (Fig. 4A, lanes 1–4). A 31 kDa protein
corresponding to the predicted size of hisGFP was
observed for Ac-hisGFP (Fig. 4A, lane 4). With the
fusion constructs, signiﬁcantly higher levels of ex-
pression of p67 recombinant fusion proteins were
observed in the CBB-stained gel (Fig. 4A, lanes 5–8)
as compared to the non-fused proteins (Fig. 2A) since
they were easily seen in the Coomassie-stained gels.
The hisGFP :p67N fusion protein (lane 5) migrated
as a 75 kDa protein as opposed to a predicted size of
53 kDa. HisGFP :p67M was expressed in 2 forms,
the expected 69 kDa protein and a 104 kDa protein
(Fig. 4B, lane 6). HisGFP :p67C was expressed as a
39 kDaprotein(Fig.4B, lane7)andhisGFP : p67DSS
as a 104 kDa protein (Fig. 4B, lane 8) as expected.
A monoclonal antibody directed against the N-
terminal hexa-histidine tag (CLONTECH)was used
to conﬁrm expression of all the fusion proteins in an
immuno-blot analysis. All the fusion proteins were
detected at the same size as observed in the protein
gel (Fig. 4B, lanes 4–8). Western blot analysis using
Fig. 5. Immuno-dot-blot analysis of hisGFP : p67 fusion
proteins. Both non-denatured and denatured puriﬁed
proteins (A and B) or total cell lysate (C) of hisGFP : p67N
and hisGFP : p67DSS were spotted on a nitrocellulose
membrane and subjected to immunoblot analysis using
monoclonal TpM12 or ARIII 22.7. TpM12 was raised
against native p67 while ARIII 22.7 was raised against
E. coli-derived p67.
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either a polyclonal antibody against GFP or mono-
clonal antibodies directed against the diﬀerent p67
domains gave similar results (not shown).
Conformation of p67 fusion proteins
The GFP-p67 fusion proteins were puriﬁed and the
SDS–PAGE analysis of eluted fractions showed that
the polyhistidine tagged proteins were eﬃciently
bound to the column and that the fractions contained
highly puriﬁed proteins (results not shown). An
immuno-dot blot analysis was performed to inves-
tigate whether the GFP-tagging aﬀected the folding
of the p67 domains in the fusion protein. A mono-
clonal antibody, TpM12, raised against native p67,
and which does not recognize E. coli-derived p67
(Musoke et al. 1984), was used as the ﬁrst antibody
in this analysis. Puriﬁed proteins as well as total cell
lysate of cells infected with AchisGFP :p67N and
AchisGFP :p67DSS were spotted on the blot. As
controls, we used hisGFP, BEV-p67 and E. coli-
derived p67N as well as a mock-infected cell lysate.
Both denatured and non-denatured samples were
analysed. As a control measure a duplicate blot was
incubated with the monoclonal antibody, ARIII
22.7, that was raised against denatured p67 and
which recognizes a linear epitope in the N-domain
(Nene et al. 1999). TpM12did not reactwith proteins
(both denatured and non-denatured) in the mock,
the BEV-p67, E. coli-derived p67N and the hisGFP
samples (Fig. 5A, lanes 1–4). TpM12 reacted with
non-denatured but not with the denatured samples
of hisGFP :p67N and hisGFP :p67DSS (Fig. 5A,
lanes 5 and 6), indicating that the GFP-p67 fusion
proteins were expressed in a near-native confor-
mation. All the protein samples (both denatured and
non-denatured) except for the negative controls re-
acted with ARIII 22.7 (Fig. 5B, lanes 1–6), conﬁrm-
ing that p67-speciﬁc proteins had been spotted on
all blots.
DISCUSSION
Low expression levels ofT. parva p67 were observed
by Nene et al. (1995) in their attempt to produce
large amounts of p67 in a more authentic form via
the baculovirus–insect cell expression system. In the
present study we expressed subdomains of T. parva
sporozoite p67 instead of the complete p67 protein to
obtain higher levels of expression. First, we expres-
sed p67 subdomains as non-fused proteins and in a
second experiment, as fusions to the C-terminus of
GFP. In both groups the native p67 signal peptide
and transmembrane region were eliminated as this
might limit expression levels (Li et al. 1994). Pepscan
and computer analyses have predicted that antigenic
sites of p67 were located in the N- and C-terminal
regions (Knight et al. 1996; Nene et al. 1999). Anti-
body responses of bovines to p67 are restricted to
these two domains (Knight et al. 1996; Nene et al.
1999). Although the middle region of p67 does not
appear to have linear B-cell epitopes, it contains sev-
eral Th-cell epitopes (Musoke, Nene & McKeever,
1995). The middle region was included in this study
since it could be used to deﬁne T-cell epitopes when
it becomes necessary to investigate the protective
capacity of peptide-based vaccines in the future.
The non-fused proteins were expressed at a low
level as was the full-length p67 protein (Nene et al.
1995). This may be due to ineﬃcient translation
of p67 transcripts or the instability of nascent p67
proteins since abundant transcripts were detected
by Northern blot analysis. A similar problem was
seen in E. coli, where p67 expressed as fusion to the
glutathione-S-transferase of Schistosoma japonicum
(Nene et al. 1992) and the non-structural protein-1
(NS1) of inﬂuenza virus A (Musoke et al. 1992) have
failed to produce stable recombinant p67 protein.
A signiﬁcantly higher level of expression of the
p67 domains was obtained when fused to GFP,
relative to the non-fused as well as full-length p67
(Nene et al. 1995). Fusion to GFP either enhanced
translation or, more likely, improved the stability
of the p67 nascent protein products, thereby increas-
ing the yield of p67 expression in insect cells. GFP
has been shown to enhance the stability and increase
the expression of fusion proteins in prokaryotic ex-
pression systems (Waldo et al. 1999; Rucker et al.
2001). Another indication that GFP could stabilize
a fused protein was obtained by Akgul et al. (2000),
when they deleted a stability-regulating motif (the
PEST sequence) from the Mc-1 protein (Sato et al.
1994; Sedlak et al. 1995) but did not ﬁnd any eﬀect
on the stability of a Mcl-GFP fusion protein.
The observed molecular mass of the hisGFP :
p67N, hisGFP :p67M and hisGFP :p67DSS recom-
binant fusion proteins in SDS–PAGE was consider-
ably higher than the calculated value. For example
the apparent molecular mass of hisGFP :p67N was
75 kDa as opposed to the predicted size of 53 kDa.
The exact reason for the anomalous behaviour of
these recombinant proteins in SDS–PAGE is not
clear. It is known that p67 undergoes N-glycosyla-
tion in insect cells (Nene et al. 1995), but this could
not explain the present observation since the signal
peptide of p67 was eliminated in these constructs.
The primary amino acid sequence of p67 may be
responsible for the aberrant mobility since a simi-
lar diﬀerence between the observed and calculated
molecular mass was observed for the non-fused p67
domains. Similar observations have been made with
recombinant p67 production in both E. coli and
insect cells (Nene et al. 1992, 1995).
A recombinant p67 in a near authentic form is
highly desirable as it might function as a better
immunogen than the previously tested NS1-p67
(Musoke et al. 1992; Nene et al. 1995). An immuno-
dot-blot analysis using a monoclonal speciﬁc for
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native p67 indicated that GFP fusions of p67N and
p67DSS had a near native folding, in contrast to the
full length p67 expressed in insect cells in a non-fused
form.
GFP is being used extensively as a visible marker
in cell biology because it operates independently of
cofactors and can be detected rapidly and easily. Due
to its small size, GFP does not signiﬁcantly increase
the size of the chimeric protein neither does it inter-
fere in general with the biological functions of even
small proteins (Tsien, 1998; Stauber et al. 1998 a, b ;
Carter & Sorkin, 1998; Waldo et al. 1999). In this
case, GFP fusion not only facilitated direct detection
and monitoring of infected insect cells, and titration
of recombinant viruses, it also increased expression
levels of a recombinant protein, and appeared to con-
serve its natural folding properties. The high-level
expression of near-authentic p67 domains is an im-
portant step towards the development of an eﬀective
subunit vaccine against ECF. Investigation of the
immunogenic properties of these products and deter-
mining the level of protection against ECF in cattle
will be the next step towards evaluating the vaccine
potential of these GFP :p67 fusion proteins.
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